Cigna Q3 adjusted EPS rises to $7.98; adjusted revenues climb 6% to $73.79 billion

• Cigna’s third-quarter 2026 adjusted EPS rose to $7.98, exceeding expectations.
• Adjusted revenues climbed 6% year over year to $73.79 billion, driven by premium growth in Cigna Healthcare and Evernorth’s drug mix.
• Pharmacy Benefit Services’ pre-tax adjusted income from operations dropped 22% to $765 million, primarily reflecting large-client contract renewals and strategic investments.
• Cigna Healthcare’s pre-tax adjusted income from operations increased 15% to $1.19 billion, exceeding expectations.
• FY26 adjusted EPS guidance increased to at least $30.60.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The CIGNA Corporation published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.